The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines

Pharmacy World and Science

Volumn 30, Issue 1, 2008, Pages 17-23

  Elliott, Rachel A ^a   Barber, Nick ^b   Clifford, Sarah ^b   Horne, Robert ^b   Hartley, Elaine ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c Alliance Pharmacy ^*  (United Kingdom)

Author keywords

Economic evaluation; England; Patient adherence; Pharmacist; Randomised controlled trial; Telephone service

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIABETES MELLITUS; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; INFORMATION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHARMACIST; PRESCRIPTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SELF REGULATION MODEL; STATISTICAL SIGNIFICANCE; STROKE; TELECONSULTATION;

AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; COST-BENEFIT ANALYSIS; ENGLAND; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PRESCRIPTIONS, DRUG; PROFESSIONAL ROLE; QUESTIONNAIRES; REMOTE CONSULTATION; TELEPHONE; TREATMENT OUTCOME;

EID: 36448981750     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9134-y     Document Type: Article

References (42)

1. Dartnell JGA, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, Nestor PJ et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996;164:659-62.
2. Psaty BM, Koepsell TD, Wagner EH, lo Gerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of B-Blockers. J Am Med Assoc 1990;263(12):1653-7.
3. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995;21(3):419-29.
4. Lau DT, Nau DP. Oral antihypoglycaemic medication nonadherence and subsequent hospitalization among individuals with Type 2 diabetes. Diabetes Care 2004;27:2149-53.
5. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of Medication Adherence and Associated Health Care Costs in an Older Population with Type 2 Diabetes Mellitus: A Longitudinal Cohort Study. Clinical Therapeutics 2003;(11):2958-71.
6. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J et al. A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 2006;333(7557):15-21.
7. Lewis A. Noncompliance: A $100 billion problem. Remington Rep 1997;5:14-5.
8. Zuger A. The 'other' drug problem: forgetting to take them. The New York Times 1998 Jun 2.
9. Coambs RB, Jarry JL, Jensen P, Her MH, Porter J, Ferguson BS et al. Prescription non-compliance and inappropriate prescribing in Canada: causes, consequences and costs. Toronto, Canada: Health Canada Publications; 1998.
10. Cerveri I, Locatelli F, Zoia MC, Corsico A, Accordini S, Marco R. International variations in asthma treatment compliance. Eur Respir J 1999;14:288-94.
11. Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003;12:280-5.
12. Elliott RA, Barber N, Horne R. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother 2005;39:508-15.
13. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. J Lancet 1996;348:383-6.
14. Campbell M, Fitzpatrick R, Haines A, Kinmonth A-L, Sandercock P, Spiegelhalter DJ. Framework for design and evaluation of complex interventions to improve health. Br Med J 2000;321:694-6.
15. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. JAMA 2006;296(21):2563-71.
16. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care 2004;13:172-5.
17. Horne R. Treatment perceptions and self regulation. In: Cameron D, Leventhal H eds., The self-regulation of health and illness behaviour.London: Routledge; 2003. p. 138-53, ISBN 0415297001.
18. Leventhal H, Cameron LD. Behavioral theories and the problem of compliance. Patient Educ Couns 1987;10:117-38.
19. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. The Cochrane Database of Systematic Reviews 2002;(Issue 2).
20. Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy 1998;3(4):233-45.
21. Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost effectiveness acceptability curves. Health Econ 2001;10:779-87.
22. National Health Service Executive. NHS Reference Costs 2004. http://www dh gov uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/ PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4069646&chk=vzKK5z 2005 [cited 2003 Jul 10];.
23. Netten A, Dennett J. Unit costs of community care. Kent: Personal Social Services Research Unit; 2005. Report No.: ISBN 1092671406.
24. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, MacDonald HG. Interventions for enhancing medication adherence. The Cochrane Database of Systematic Reviews 20054(Art. No.: CD000011.pub2.).
25. NHS Business Services Authority Prescription Pricing Division. New Contractual Framework for Community Pharmacy: Payment for Advanced Services; Medication Use Reviews. http://www ppa org uk/ppa/ contract_framework_for_community_pharmacy htm#medsusereview 2007 [cited 2007 Jan 12];.
26. Myers LB, Midence K. Methodological and conceptual issues in adherence. In: Myers LB, Midence K, (eds.), Adherence to treatment in medical conditions. Amsterdam: Harwood Academic Publishers; 1998. ISBN 9057022648.
27. Milgrom H, Bender BG, Ackerson LM, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
28. Bender BG, Milgrom H, Rand C, Ackerson LM. Psychological factors associated with medication non-adherence in asthmatic children. J Asthma 1998;35:347-53.
29. Bender BG, Wamboldt FS, O'Connor SL, Rand C, Szefler S, Milgrom H et al. Measurement of children's asthma medication adherence by self-report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000;85:416-21.
30. Nichol MB, Venturini F, Sung JCY. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999;33:531-40.
31. Choo PW, Rand CS, Inui TS, Lee M, Cain E, Cordeiro-Breault M et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57.
32. Matthews DR, Stratton IM, Aldington SJ, Homan RR, Kohner EM. UKPDS 69 Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus. Arch Ophthal 2004;122:1631-40.
33. Simpson SH, Johnson JA, Biggs C, Biggs RS, Kuntz A, Semchuk W et al. Practice-based research: Lessons from community pharmacist participants. Pharmacotherapy 2001;21(6):731-9.
34. Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial. Int J Pharm Pract 2000;8:165-75.
35. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pharmacol 1995;49:173-6.
36. Department of Health. NHS R & D Strategic Review Primary Care Working Group: Report of the Pharmacy subgroup. https://www dh gov uk/assetRoot/04/02/ 09/41/04020941 pdf 1999 [cited 2006 Jul 10].
37. Department of Health. Pharmacy in the future: Implementing the NHS Plan. http://195 33 102 76/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en? CONTENT_ID=4005917&chk=/4q1tW 2000 [cited 2006 Jul 10].
38. Department of Health. A vision for pharmacy in the new NHS. http://www dh gov uk/Consultations/ClosedConsultations/ClosedConsultationsArticle/fs/en? CONTENT_ID=4068353&chk=Y2fMuy 2003 July [cited 2006 Jul 10].
39. Department of Health. National Service Framework for Coronary Heart Disease. www dh gov uk/PolicyAndGuidance/HealthAndSocialCareTopics/ CoronaryHeartDisease/fs/en 2000 [cited 2006 Jul 10].
40. Department of Health. National Service Framework for Older People. www dh gov uk/PolicyAndGuidance/HealthAndSocialCareTopics/olderpeople/fs/en 2001 [cited 2006 Jul 10].
41. Department of Health. National Service Framework for Diabetes. www dh gov uk/PolicyAndGuidance/HealthAndSocialCareTopics/diabetes/fs/en 2003 [cited 2006 Jul 10].
42. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47(6):555-67.